Siga Technologies (SIGA) Capital Expenditures (2010 - 2025)
Siga Technologies (SIGA) posted Capital Expenditures of $289576.0 for Q3 2025, up 28957500.0% on a QoQ basis from $1.0 in Q2 2025, and up 1191.19% year-over-year from $22427.0 in Q3 2024.
Siga Technologies (SIGA) Capital Expenditures (2010 - 2025) Analysis & Trends
Siga Technologies' Capital Expenditures history runs 15 years deep, the most recent figure standing at $289576.0 for Q3 2025.
- Quarterly Capital Expenditures rose 1191.19% year-over-year to $289576.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $332308.0 (up 1250.19% YoY) and the FY2024 annual result came in at $42450.0, up 95.75% from the prior year.
- Capital Expenditures was $289576.0 for Q3 2025 at Siga Technologies, up from $1.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $289576.0 in Q3 2025 and bottomed at $1.0 in Q2 2025.
- A 4-year average of $42922.6 and a median of $19762.0 in 2023 frame the typical range for Capital Expenditures.
- Peak annual rise in Capital Expenditures reached 1191.19% in 2025, while the deepest fall reached 99.95% in 2025.
- Siga Technologies' Capital Expenditures stood at $26196.0 in 2021, then decreased by 17.22% to $21686.0 in 2023, then decreased by 17.74% to $17838.0 in 2024, then soared by 1523.37% to $289576.0 in 2025.
- Business Quant data shows SIGA's Capital Expenditures at $289576.0 in Q3 2025, $1.0 in Q2 2025, and $24893.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 168.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 110.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.95 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 99.60 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 39.90 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 1.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 51.00 Mn |
| 10 | Siga Technologies | 225.56 Mn | 70.59 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 289,576.00 |
| Sep 30, 2025 | 289,576.00 |
| Jun 30, 2025 | 1.00 |
| Jun 30, 2025 | 1.00 |
| Mar 31, 2025 | 24,893.00 |
| Mar 31, 2025 | 24,893.00 |
| Dec 31, 2024 | 17,838.00 |
| Dec 31, 2024 | 17,838.00 |
| Sep 30, 2024 | 22,427.00 |
| Sep 30, 2024 | 22,427.00 |
| Jun 30, 2024 | 2,185.00 |
| Jun 30, 2024 | 2,185.00 |
| Jun 30, 2023 | 21,686.00 |
| Jun 30, 2023 | 21,686.00 |
| Dec 31, 2021 | 26,196.00 |
| Dec 31, 2021 | 26,196.00 |
| Jun 30, 2021 | 10,700.00 |
| Jun 30, 2021 | 10,700.00 |
| Mar 31, 2021 | 13,724.00 |
| Mar 31, 2021 | 13,724.00 |